Company / Return on Assets (ROA)
Edesa Biotech, Inc. Return on Assets (ROA) History
FY2014-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-43.6%
FY2021
5-year range
-65.2% / -25.8%
FY2017-FY2021
Trend
-69.1%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) has fluctuated over the past 7 years, ranging from -100.2% in FY2015 to -25.8% in FY2020.
Based on SEC 10-K filings.
-43.6% in FY2021 with a 5-year CAGR of +21.6%.
Declined from -42.7% to -43.6% over the past 3 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -0.9pp
- 5-Year Change
- +21.6pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2021, return on assets (roa) decreased 69.1% year-over-year.
- Peak return on assets (roa) was recorded in FY2020.
- Lowest return on assets (roa) in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2021 | -43.6% | -69.1% |
| FY2020 | -25.8% | +39.6% |
| FY2018 | -42.7% | -16.0% |
| FY2017 | -36.8% | +43.5% |
| FY2016 | -65.2% | +34.9% |
| FY2015 | -100.2% | -54.2% |
| FY2014 | -65.0% | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026